Apolipoprotein E E3/E4 genotype is associated with an increased risk of coronary atherosclerosis in patients with
Guoliang Wei1, Bin Li2, Hao Wang2
1Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China. weiguoliangmz@126.com.
Insights
The APOE ɛ3/ɛ4 genotype is an independent risk factor for coronary atherosclerosis in hypertensive patients, alongside overweight, advanced age, smoking, diabetes, and hyperlipidemia.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Epidemiology
Background:
- Apolipoprotein E (APOE) gene polymorphisms are linked to coronary atherosclerosis and hypertension.
- The specific role of APOE polymorphisms in coronary atherosclerosis risk among hypertensive individuals remains unclear.
Purpose of the Study:
- To investigate the association between APOE gene polymorphisms and the susceptibility to coronary atherosclerosis in patients with hypertension.
Main Methods:
- Retrospective analysis of 1713 hypertensive patients.
- Genotyping of APOE rs429358 and rs7412 polymorphisms.
- Statistical analysis to determine the relationship between APOE genotypes and coronary atherosclerosis risk.
Main Results:
- The APOE ɛ3/ɛ4 genotype frequency was significantly higher in hypertensive patients with coronary atherosclerosis (16.4%) compared to controls (10.9%).
- Independent risk factors identified include overweight (BMI ≥ 24.0 kg/m²), advanced age (≥ 65 years), smoking history, diabetes mellitus, and hyperlipidemia.
- APOE ɛ3/ɛ4 genotype was significantly associated with an increased risk of coronary atherosclerosis (OR: 1.514, 95% CI: 1.133-2.024).
Conclusions:
- Overweight, advanced age, smoking, diabetes mellitus, and the APOE ɛ3/ɛ4 genotype are independent risk factors for coronary atherosclerosis in hypertensive patients.
- These findings highlight the importance of genetic predisposition, specifically the APOE ɛ3/ɛ4 genotype, in the development of coronary atherosclerosis within the hypertensive population.
Objective:
Apolipoprotein E (APOE) gene polymorphisms were associated with coronary atherosclerosis and hypertension. However, the relationship between APOE polymorphisms and coronary atherosclerosis susceptibility in hypertensive patients is unclear. The aim of this study was to assess the relationship.
Methods:
A total of 1713 patients with hypertension who were admitted to Meizhou People's Hospital from November 2019 to August 2023 were retrospectively analyzed, including 848 patients with coronary atherosclerosis and 865 patients without coronary atherosclerosis. The rs429358 and rs7412 polymorphisms of APOE were genotyped, and relationship between APOE polymorphisms and the risk of coronary atherosclerosis in hypertensive patients were analyzed.
Results:
There were 10 (0.6%), 193 (11.3%), 30 (1.8%), 1234 (72.0%), 233 (13.6%), and 13 (0.8%) individuals with APOE ɛ2/ɛ2, ɛ2/ɛ3, ɛ2/ɛ4, ɛ3/ɛ3, ɛ3/ɛ4, and ɛ4/ɛ4 genotype, respectively. The frequency of APOE ɛ3/ɛ4 was higher (16.4% vs. 10.9%, p = 0.001) in the patients with coronary atherosclerosis than controls. Logistic analysis showed that body mass index (BMI) ≥ 24.0 kg/m2 (24.0 kg/m2 vs. 18.5-23.9 kg/m2, odds ratio (OR): 1.361, 95% confidence interval (CI): 1.112-1.666, p = 0.003), advanced age (≥ 65/<65, OR:1.303, 95% CI: 1.060-1.602, p = 0.012), history of smoking (OR: 1.830, 95% CI: 1.379-2.428, p < 0.001), diabetes mellitus (OR: 1.380, 95% CI: 1.119-1.702, p = 0.003), hyperlipidemia (OR: 1.773, 95% CI: 1.392-2.258, p < 0.001), and APOE ɛ3/ɛ4 genotype (ɛ3/ɛ4 vs. ɛ3/ɛ3, OR: 1.514, 95% CI: 1.133-2.024, p = 0.005) were associated with coronary atherosclerosis in hypertensive patients.
Conclusions:
Overweight (BMI ≥ 24.0 kg/m2), advanced age, history of smoking, diabetes mellitus, and APOE ɛ3/ɛ4 genotype were independent risk factors for coronary atherosclerosis in hypertensive patients.
More Related Videos
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Factors affecting Blood pressure
Physiological Factors:
